中国医科大学学报2024，Vol.53Issue(7)：616-620,5.DOI:10.12007/j.issn.0258-4646.2024.07.007
改良衰弱指数联合外科Apgar评分对腹腔镜结直肠癌根治术老年患者术后并发症的预测效能
Modified frailty index combined with surgical Apgar score for predicting postoperative complications in elderly patients undergoing laparoscopic radical resection of colorectal cancer
摘要
Abstract
Objective To explore the efficacy of an 11-item modified frailty index(mFI-11)combined with surgical Apgar score(SAS)for predicting postoperative complications in elderly patients with colorectal cancer undergoing laparoscopic radical resection.Methods We enrolled a total of 481 elderly patients(aged≥65 years)undergoing laparoscopic radical resection of colorectal cancer.We performed a frailty assessment preoperatively using mFI-11 and calculated the SAS based on the lowest mean arterial pressure and heart rate as well as blood loss during surgery.Finally,we compared the clinical data,mFI-11,and SAS of patients with and without post-operative complications,and then analyzed their relationship with the postoperative complications and predictive values.Results The mFI-11,SAS,and operation time independently correlated with postoperative complication occurrence(P<0.05).The AUC of post-operative complications obtained using the mFI-11,SAS,and operation time were 0.805,0.800,and 0.610,respectively.The AUC of the postoperative complications derived from mFI-11 combined with SAS was 0.902.Conclusion In elderly patients undergoing laparo-scopic radical resection of colorectal cancer,the mFI-11,SAS,and operation time significantly correlated with postoperative complication occurrence.The combination of mFI-11 and SAS displayed a higher predictive power for postoperative complications compared to the use of a single indicator,which it could provide a reliable basis for early clinical identification of complications and reduce their occurrence.关键词
衰弱/Apgar评分/术后并发症Key words
frailty/Apgar score/postoperative complication分类
医药卫生引用本文复制引用
杨新霞,徐霞,陈冬冬..改良衰弱指数联合外科Apgar评分对腹腔镜结直肠癌根治术老年患者术后并发症的预测效能[J].中国医科大学学报,2024,53(7):616-620,5.基金项目
浙江省中医药科技计划(2024ZL941) （2024ZL941）
